Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
Company Executives Share Strategic Vision and Engage with Investors Live at VirtualInvestorConferences.com
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Sciences Virtual Investor Forum, taking place June 24th & 25th, 2026.
Individual investors, institutional investors, advisors, and analysts are invited to attend.
Investors are encouraged to pre-register and run the online system check to expedite participation and receive event updates. Participation is free, and attendees may watch live company presentations and schedule one-on-one meetings with management teams.
Schedule 1x1 meetings here.
"This week's Life Sciences Virtual Investor Forum brings together a compelling roster of innovators from across the sector," said Greg Young, AVP, Investor Access, OTC Markets. "Our Virtual Investor Conferences continue to provide an efficient platform for these companies to engage directly with investors and communicate their strategies."
June 24th
| Presentation Time (ET) |
Company | Ticker(s) |
| 10:30 AM ET | MetaVia Inc. | (NASDAQ: MTVA) |
| 11:00 AM ET | Nasus Pharma Ltd. | (NYSE American: NSRX) |
| 11:30 AM ET | CytoSorbents Corporation | (NASDAQ: CTSO) |
| 12:00 PM ET | PetVivo Holdings Inc. | (OTCQX: PETV) |
| 1:00 PM ET | Jaguar Health, Inc. | (NASDAQ: JAGX) |
| 1:30 PM ET | Reviva Pharmaceuticals Holdings, Inc. | (OTCQB: RVPH) |
| 2:00 PM ET | Zivo Bioscience, Inc. | (OTCID: ZIVO) |
| 3:00 PM ET | 4DMedical Limited | (Pink: FDMDF | ASX: 4DX) |
June 25th
| Presentation Time (ET) |
Company | Ticker(s) |
| 9:30 AM ET | Prostatype Genomics AB | (OTCQB: PGABF | NASDAQ Stockholm: PROGEN) |
| 10:00 AM ET | Abingdon Health plc | (OTCQB: ABDXF | LSE: ABDX) |
| 10:30 AM ET | Innovotech, Inc. | (OTCQB: IOTCF | TSXV: IOT) |
| 11:00 AM ET | Lakewood-Amedex Biotherapeutics Inc. | (NASDAQ: LABT) |
| 11:30 AM ET | Kelyniam Global, Inc. | (OTCID: KLYG) |
| 12:00 PM ET | IMUNON, Inc. | (NASDAQ: IMNN) |
| 12:30 PM ET | Promino Nutritional Sciences Inc. | (OTCID: MUSLF | CSE: MUSL) |
| 1:00 PM ET | Envoy Medical Inc. | (NASDAQ: COCH) |
| 1:30 PM ET | Coiled Therapeutics plc | (OTCQB: COTXF | AIM: COIL) |
| 2:00 PM ET | Aspire Biopharma Holdings Inc. | (NASDAQ: ASBP) |
| 2:30 PM ET | Rocket Doctor AI Inc. | (OTCQB: AIRDF | CSE: AIDR) |
| 3:00 PM ET | Phio Pharmaceuticals Corp. | (NASDAQ: PHIO) |
| 3:30 PM ET | aTyr Pharma, Inc. | (NASDAQ: ATYR) |
| 4:00 PM ET | NuFarm Ltd. | (Pink: NUFMF | ASX: NUF) |
To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com.
About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.
Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.
Media Contact:
OTC Markets Group Inc. +1 (212) 896-4428, media@otcmarkets.com
Virtual Investor Conferences Contact:
Greg Young
VP Corporate Services
OTC Markets Group
(212) 652-5958
greg@otcmarkets.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
